02309oam 2200457Ia 450 991069757080332120080915165423.0(CKB)5470000002389243(OCoLC)181643937(EXLCZ)99547000000238924320071120d2007 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierThe top five outpatient prescription drugs ranked by total expense for Medicare beneficiaries, by insurance status, 2004[electronic resource] /Marie N. Stagnitti[Rockville, Md.] :Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality,[2007]4 unnumbered pages illustrations, tablesStatistical brief ;#186Title from title screen (viewed Sept. 15, 2008)."September 2007.""The estimates in this brief are derived from the Household Component of the 2004 Medical Expenditure Panel Survey (MEPS-HC)"--P. [1].Includes bibliographical references (page [4]).This statistical brief provides information on the top five outpatient prescription medicines ranked by total expenditures and insurance status for the Medicare population, as reported by households in the U.S. civilian noninstitutionalized (community) population in calendar year 2004. This brief also provides information on average total payments and average out-of-pocket payments per purchase for the top five drugs for Medicare beneficiaries, by insurance status.MedicarePharmaceutical services insuranceUnited StatesPrescription pricingUnited StatesMedicare.Pharmaceutical services insurancePrescription pricingStagnitti Marie N1386624United States.Agency for Healthcare Research and Quality.Medical Expenditure Panel Survey (U.S.)VVKVVKGPOBOOK9910697570803321The top five outpatient prescription drugs ranked by total expense for Medicare beneficiaries, by insurance status, 20043516348UNINA